Ousia Pharma logo Omega Funds Logo . Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplas ...

Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centersFinancing ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to attack cancer. Soon, Maryland will be home to one of the largest facilities ...

The AstraZeneca PLC ADR AZN advanced 2.74% to $72.44 Friday, on what proved to be an all-around positive trading session for ...

AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...

In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

European stocks closed higher on Wednesday, as investors pored through another slew of earnings and reacted to ...

AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said ...

LONDON (Reuters) -The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance ...